Figure 4

Correlation between APRI > 0.5 and cardiovascular risk in non-metabolic and metabolic subjects, classification by age and comparison in prediabetes and Diabetes Mellitus subjects. (a,b) Correlation analysis of APRI and cardiovascular risk (CVR) in non-metabolical (MetS NO) and MetS (MetS YES) subjects with APRI > 0.5. (c) Classification of MetS subjects in age ranges; subjects were divided by APRI levels with a cut-off of 0.5 to identify elevated APRI. Data is presented as mean ± SEM. Statistical significance was assessed by Student T-test (**p < 0.01). Multipliers are shown to identify difference in CVR in subjects with APRI > 0.5 compared to subjects with APRI < 0.5 of the same age. (d) Comparison of CVR in healthy and Diabetes Mellitus (DM) subjects divided by APRI levels. Data is presented as mean ± SEM. Statistical significance was assessed by Student T-test (*p < 0.05, **p < 0.01). Multipliers are shown to identify difference in CVR in subjects with APRI > 0.5 compared to subjects with APRI < 0.5 of the same age. (e) Comparison of CVR in PreDiabetes (preDM), Diabetes Mellitus (DM) and Metabolic (MetS) subjects divided by APRI levels. Data is presented as mean ± SEM. Statistical significance was assessed by Student T-test (*p < 0.05, **p < 0.01). Multipliers are shown to identify difference in CVR in subjects with APRI > 0.5 compared to subjects with APRI < 0.5 of the same group.